Virtus Investment Advisers’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Virtus Investment Advisers's HALO Position: Q1 2026 in Review
Virtus Investment Advisers increased its Halozyme (HALO) stake by 24% in Q1 2026, buying an estimated $182K and bringing the position to 13,571 shares worth $877K. The position accounts for 0.24% of the portfolio, ranked #156.
Virtus Investment Advisers first reported a position in HALO in Q3 2022 and has held it in 15 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Virtus Investment Advisers held 13,571 shares of Halozyme worth $877K as of Q1 2026.
- Virtus Investment Advisers bought 2,587 Halozyme shares in Q1 2026, an estimated $182K.
- Halozyme made up 0.24% of Virtus Investment Advisers's portfolio in Q1 2026, its #156 holding.
- Virtus Investment Advisers first reported a position in Halozyme in Q3 2022 and has held it in 15 quarters since.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.